Corvus Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
CRVS Nasdaq 2830 www.corvuspharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals to Present at the 2026 Cantor Global Healthcare Conference - Sep 3rd, 2026 6:30 am
Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial - Aug 27th, 2026 5:30 am
Corvus Pharmaceuticals (CRVS): This Clinical-Stage Drugmaker Just Got A Lot More Interesting - Aug 17th, 2026 9:16 am
Corvus Pharmaceuticals (CRVS) Q2 2026 Earnings Call Transcript - Aug 14th, 2026 9:42 am
Corvus Pharmaceuticals Inc (CRVS) (Q2 2026) Earnings Call Highlights: Advancing Soquelitinib ... - Aug 6th, 2026 11:09 pm
Corvus Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary - Aug 6th, 2026 9:43 pm
Corvus Pharmaceuticals Q2 Earnings Call Highlights - Aug 6th, 2026 6:03 pm
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results - Aug 6th, 2026 2:01 pm
Corvus Pharmaceuticals to Provide Business Update and Second Quarter 2026 Financial Results on August 6, 2026 - Jul 30th, 2026 2:01 pm
Corvus Pharmaceuticals Director Buys 21,700 Shares. Does This Mean CRVS a Buy? - Jun 23rd, 2026 1:40 pm
Corvus Pharmaceuticals Faces Key Soquelitinib Data And Possible M&A Interest - Jun 14th, 2026 4:09 pm
Is Corvus Pharmaceuticals, Inc. (CRVS) A Good Stock To Buy Now? - Jun 13th, 2026 9:53 am
Corvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in China - Jun 9th, 2026 5:30 am
Adams Street Partners Exits Its 223,000-Share Paymentus (PAY) Position for $5.9 Million - May 24th, 2026 7:42 am
Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference - May 20th, 2026 2:01 pm
Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase - May 17th, 2026 2:46 pm
Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting - May 14th, 2026 5:00 am